Case Studies

EU HTA Regulation January 2025 – Are you ready?
With the start of the application of the EU HTAR on January 12, 2025, Suzette Matthijsse reflects on this milestone date and reiterates our commitment to contributing to the goals of the Regulation .
View Jan 13, 2025
Using Real World Data to Guide Precision Oncology Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View Nov 25, 2024